Articles mentioning Bristol-Myers Squibb Co. (BMY)

Results 11 - 20 of 746 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY

Dividends & Income Investing | October 04, 2014

Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?

S&P 500 companies paid out $91.5 billion in dividends last quarter. Unfortunately, not all dividend stocks are created equally. Let's examine two of Big Pharma's highest-yielding stocks to determine which is the better dividend stock.

Investing | September 04, 2014

Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson

Sales of Bristol-Myers Squibb and Pfizer's Eliquis are heading higher, threatening Johnson & Johnson's market leadership among factor Xa anticoagulant drugs.

Investing | July 24, 2014

Bristol-Myers Squibb's Second-Quarter Reflects a Company in Transition

Bristol-Myers Squibb revenue fell by 4% in the second quarter, due mostly to its exit from the diabetes market.

Investing | July 15, 2014

2 Reasons to Watch Bristol-Myers Squibb Co

Bristol-Myers Squibb is winning big in Japan, can they bring that success home?

Investing | July 12, 2014

This Week in Biotech: Anacor's FDA A-OK and AbbVie's Insatiable Urge to Buy Something

Anacor gets a key pipeline product approved, Bristol-Myers prepares for a landmark new drug filing, and AbbVie continues its never-ending quest to buy Shire.

Investing | July 07, 2014

Is Bristol-Myers Squibb Co. Destined for Greatness?

Let's see what the numbers say about Bristol-Myers Squibb (BMY).

Investing | July 07, 2014

Monday’s Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance

Spectrum, Bristol-Myers Squibb, GSK, and Theravance are the top biotech stocks to watch this morning.

Investing | June 23, 2014

Biotech M&A: Do We Need a New Driver?

Hepatitis C acquisitions like we've seen from Gilead, Bristol-Myers Squibb, and Merck can't last forever.

Investing | June 16, 2014

Should Pfizer Buy Bristol-Myers Squibb Instead of AstraZeneca?

Yes, Pfizer should buy Bristol-Myers Squibb instead of AstraZeneca, but it won't.

Investing | June 13, 2014

The 3 Best Big Pharma Dividend Stocks of the Past 10 Years

Big pharma's been in a funk over the recent past with the patent cliff and the recession, but these three stocks have delivered for investors.

Results 11 - 20 of 746 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY


Advertisement